Filing Details

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

SCHEDULE 13G

(Rule 13d-102)

 

INFORMATION TO BE INCLUDED IN THE STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b)

 

(Amendment No. 1)*

 

Comera Life Sciences Holdings, Inc.

(Name of Issuer)

 

Common Stock, par value $0.0001 per share

(Title of Class of Securities)

 

         20037C108         

(CUSIP Number)

 

           June 10, 2022         

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

☐ Rule 13d-1(b)

 

☒ Rule 13d-1(c)

 

☐ Rule 13d-1(d)

 

*

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

SCHEDULE 13G
CUSIP NO. 20037C108	Page 2 of 6

 

1	NAMES OF REPORTING PERSONS  I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)   Maxim Partners LLC
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP   (a) ☐ (b) ☑
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION   New York

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5	SOLE VOTING POWER Common Stock equal to less than 5%
	6	SHARED VOTING POWER   0
	7	SOLE DISPOSITIVE POWER   Common Stock equal to less than 5%
	8	SHARED DISPOSITIVE POWER   0

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON   Common Stock equal to less than 5%
10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES   ☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)   Less than 5%
12	TYPE OF REPORTING PERSON   OO

 

 

SCHEDULE 13G
CUSIP NO. 20037C108	Page 3 of 6

 

1	NAMES OF REPORTING PERSONS  I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)   Michael Rabinowitz
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP   (a) ☐ (b) ☑
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION   United States of America

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5	SOLE VOTING POWER Common Stock equal to less than 5%
	6	SHARED VOTING POWER   0
	7	SOLE DISPOSITIVE POWER   Common Stock equal to less than 5%
	8	SHARED DISPOSITIVE POWER   0

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON   Common Stock equal to less than 5%
10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES   ☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)   Less than 5%
12	TYPE OF REPORTING PERSON   IN

 

 

SCHEDULE 13G
CUSIP NO. 20037C108	Page 4 of 6

 

Item 1(a).

Name of Issuer:

 

Comera Life Sciences Holdings, Inc. (the “Issuer”)

 

Item 1(b).

Address of Issuer’s Principal Executive Offices:

 

12 Gill Street, Suite 4650

Woburn, Massachusetts 01801

 

Items 2(a), (b) and (c).

Name of Persons Filing, Address of Principal Business Office and Citizenship:

 

This Amendment No. 1 to Schedule 13G is being filed on behalf of Maxim Partners LLC and Michael Rabinowitz, as joint filers (collectively, the “Reporting Persons”).

 

The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed with this Amendment No. 1 to Schedule 13G as Exhibit 1, pursuant to which the Reporting Persons have agreed to file this Amendment No. 1 to Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended.

 

The principal business office of the Reporting Persons is 300 Park Avenue, 16^th Floor, New York, NY 10022. For citizenship, see Item 4 of each cover page.

 

Item 2(d).

Title of Class of Securities:

 

Common Stock, par value $0.0001 per share (the “Common Stock”)

 

Item 2(e).

CUSIP Number:

 

20037C108

 

Item 3.

Not applicable

 

Item 4.

Ownership.

 

(a)

Amount beneficially owned:

 

Common Stock equal to less than 5%

 

(b)

Percent of class: Less than 5%

 

(c)

Number of shares to which such person has:

 

(i)

Sole power to vote or direct the vote: Common Stock equal to less than 5%

 

 

SCHEDULE 13G
CUSIP NO. 20037C108	Page 5 of 6

 

(ii)

Shared power to vote or direct the vote: 0

 

(iii)

Sole power to dispose or to direct the disposition of: Common Stock equal to less than 5%

 

(iv)

Shared power to dispose of or direct the disposition of: 0

 

* This statement is filed on behalf of Maxim Partners LLC (“Maxim”) and Michael Rabinowitz. Mr. Rabinowitz is the manager of Maxim. Mr. Rabinowitz may be deemed to be the beneficial owner of the shares of Common Stock beneficially owned by Maxim. Mr. Rabinowitz expressly disclaims beneficial ownership of all shares of Common Stock beneficially owned by Maxim.

 

Item 5.

Ownership of Five Percent or Less of a Class.

 

If this statement is being filed to report the fact that as of the date hereof the reporting persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X].

 

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

 

Not applicable

 

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported By the Parent Holding Company.

 

Not applicable

 

Item 8.

Identification and Classification of Members of the Group.

 

Not applicable

 

Item 9.

Notice of Dissolution of a Group.

 

Not applicable

 

Item 10.

Certification.

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 

SCHEDULE 13G
CUSIP NO. 20037C108	Page 6 of 6

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: June 16, 2022

 

	MAXIM PARTNERS LLC
	By:	/s/ Michael Rabinowitz
		Michael Rabinowitz, its manager
		/s/ Michael Rabinowitz
		Michael Rabinowitz